Summary All-trans retinoic acid (RA) was previously shown to regulate the growth of gastric cancer cells derived from the cell line SC-Mi. This study was designed to investigate the effect of RA on the sensitivity of SC-Mi cells to lymphokine-activated killer (LAK) activity. RA at the concentration range of 0.001-10 kM was shown to induce SC-Mi cells to exhibit resistance to LAK activity in a dose-dependent manner. A kinetics study indicated that a significantly increased resistance was detected after 2 days of co-culturing SC-Mi cells with RA and reached a maximum after 6 days of culture. Similar results were obtained from two other cancer cell lines: promyelocytic leukaemia HL-60 and hepatic cancer Hep 3B. A binding assay demonstrated that the binding efficacy between target SC-M1 cells and effector LAK cells was not altered by RA. Flow cytometric analyses revealed that RA exhibited no effect on the expression of cell surface molecules, including HLA class and class 11 antigens, intercellular adhesion molecule-1 and -2, and lymphocyte function antigen-3. Cell cycle analysis revealed that culture of SC-Mi cells with RA resulted in an increase in GJG, phase and a decrease in S phase, accompanied by a decrease in cyclin A and cyclin Bi mRNA as determined by Northern blot analysis. Additionally, RA was shown to enhance the expression of retinoic acid receptor a (RARa) in SC-Mi cells, and to have no effect on the expression of RARfi or RARy. Taken together, these results indicate that RA can significantly increase gastric cancer cells SC-Mi to resist LAK cytotoxicity by means of a cytostatic effect through a mechanism relating to cell cycle regulation. The prevailing ideas, such as a decrease in effector to target cell binding, a reduced MHC class antigen expression or an altered RARP expression, are not involved.
Differentiation induction is a new treatment modality for cancer (Dmitrovsky et al, 1990; Degos, 1992) . Retinoids are well-known differentiation-enhancing agents and have been shown to exert antineoplastic activities in vitro against a variety of cancers, including acute promyelocytic leukaemia, germ cell tumours, breast cancer, head and neck squamous cell carcinoma, myeloma and neuroblastoma (Strickland and Sawey, 1980; Butler and Fontana, 1992; Zou et al, 1994; Cohen et al, 1995; Palumbo et al, 1995) . Furthermore, all-trans retinoic acid (RA) has been used effectively in vivo to treat acute promyelocytic leukaemia patients (Huang et al, 1988; Degos, 1992; Warrell et al, 1991 Warrell et al, , 1993 . Recently, our laboratory demonstrated that RA regulated the growth of a gastric cancer cell line, SC-MI, and induced morphological changes (Shyu et al, 1995) , suggesting that RA is also of potential in the treatment of gastric cancer by differentiation induction.
Retinoic acid has been shown to modulate immunological functions by a variety of mechanisms, including the enhancement of antibody response to antigens, T-lymphocyte-mediated immune response, phagocytosis by macrophages, lymphokine-activated killer (LAK) activity and natural killer cell activity (Athanassiades, 1981; Dillehay et al, 1988; Lin and Chu, 1990; Villa et al, 1993; Fegan et al, 1995) . Therefore, combined use of RA with cytokines, such as interleukin 2 (IL-2), has been considered in anti-cancer treatment (Bollag and Peck, 1993 ). Yet the exact mechanisms underlying the effectiveness of RA, especially its direct action on tumour cells, remain unclear. Retinoic acid binds to and induces the expression of retinoic acid receptors (RARs) and retinoid x receptors (RXRs), which activate gene expression to initiate the mechanisms that control cellular differentiation and cell growth (Love and Gudas, 1994) . Treatment of cancer cells with RA is frequently accompanied by alterations of tumour cell surface proteins, including intercellular adhesion molecule (ICAM) (Triozzi et al, 1992 ; Bouillon and Audette, 1994) . These complex (MHC) class I molecules and the alteration of RARP, are not involved. These results may also advise caution as to the suitability of RA with LAK cells or IL-2 biotherapy in certain cancers, especially in the light of the most recent report describing the combination of ,-carotene and vitamin A as having no benefit and possibly an adverse effect on lung cancer (Omenn et al, 1996) .
MATERIALS AND METHODS Target cells
Three cancer cell lines, including gastric cancer SC-MI, promyelocytic leukaemia HL-60 and hepatic cancer Hep 3B, were used as target cells in the cytotoxicity assay. Tumour cells were maintained in RPMI-1640 medium with 10% fetal calf serum (FCS) (Gibco, Grand Island, NY, USA).
Recombinant IL-2 IL-2 was kindly provided by Cetus Oncology Corperation (Emeryville, CA, USA).
Generation of LAK killer cell activity LAK cell activity was generated as described previously (Chao et al, 1990 (Chao et al, , 1995a . Briefly, peripheral blood mononuclear cells (PBMCs) were obtained from normal healthy volunteers and incubated at 37°C in complete medium containing 3000 IU ml-' IL-2, under a moist atmosphere with 5% carbon dioxide in culture flasks at a cell concentration of 2-3 x 106 ml'. Complete medium contained RPMI-1640 with 10% FCS, 0.3 mg ml-1 L-glutamine, 100 gg ml-' streptomycin and 100 U ml-' penicillin. Activated killer cells were harvested after culture for 4 days and washed twice with RPMI-1640. The viable cells were counted and resuspended in RPMI-1640 containing 10% FCS for the standard 4-h 5'Cr-release assay (Chao et al, 1990 (Chao et al, , 1995a , and for surface marker studies with flow cytometry (Chao et al, 1995b ).
Co-culturing cancer cells with RA RA (j-all-trans, Sigma, St Louis, MO, USA) was dissolved in a small amount of dimethyl sulphoxide (Sigma) to make a stock solution of 0.01 M. This solution was used at a final concentration ranging from 0.001-10 gM in complete medium. RA was added to the culture medium at the beginning of the culture. After incubation for various periods of time, tumour cells were harvested, washed and used as target cells in the standard 4-h 51Cr-release assay. Preliminary experiments showed dimethyl sulphoxide alone at the concentrations used had no effect on the susceptibility of cancer cells to LAK cytotoxicity.
In vitro cytotoxicity assay
The standard 4-h 5'Cr-release microcytotoxicity assay was performed as described (Chao et al, 1990 (Chao et al, , 1995a 
Cell cycle analysis
Cell cycle analysis was performed by using flow cytometry as previously described (Shyu et al, 1995) . Briefly, cells in logarithmic growth were labelled with 5 mm bromodeoxyuridine for 20 min. Cells were then harvested and fixed in 70% ethanol. Nuclei were prepared by incubating cells in 0.04% pepsin, 0.1 N hydrochloric acid for 20 min at room temperature, followed by the addition of 2 N hydrochloric acid at 37°C for 30 min. Following neutralization with 0.1 M sodium borate, nuclei were stained with anti-bromodeoxyuridine monoclonal antibody (Becton-Dickinson) at room temperature for 30 min and fluorescein-labelled goat anti-mouse antibody (1:50) (Sigma) for 30 min. Nuclei were then stained with 10 gg ml-' propidium iodide, 5 mg ml-' RNAase overnight at 4°C and analysed by FACScan. The fractions of cells in GO/GI, S and G2/M phases were analysed using the LYSYS program.
Binding assay Target cells (1 x 105) and LAK cells (5 x 105) are mixed in 0.2 ml of complete medium in an Eppendorf tube and incubated for 5 min at 37°C in a humidified 5% carbon dioxide atmosphere. The tubes were then centrifuged for 30 s, after which the pellet was pipetted gently three times and resuspended and incubated for another 5 min at 37°C in a humidified 5% carbon dioxide atmosphere. The percentage binding of effector cells to target cells was determined by counting at least 200 target cells.
RNA preparation and Northern blot analysis Poly (A)+ RNA preparation and Northern blot analysis were performed as previously described (Shyu et al, 1995 (1997) 75(9), [1284] [1285] [1286] [1287] [1288] [1289] [1290] 0 Cancer Research Campaign 1997 with oligo-dT cellulose (Boehringer Mannhiem) in the same buffer containing 0.5 M sodium chloride at room temperature for 1 h on a rotary shaker. After washing, RNA was eluted with 0.01 M Tris-HCl, pH 7.5. RNA was then fractionated on a 1.1% agarose, 1.1% formaldehyde gel in 5 mm NaOAc, 1 mm EDTA, 20 mm 3-[N-morpholino] propanesulphonic acid, pH 7.0, and transferred to a nylon membrane by capillary blotting in 20 x saline sodium citrate (SSC) (3 M sodium chloride, 0.3 M sodium citrate, pH 7.0). Blots were UV-fixed prehybridized and hybridized at 42°C in buffer containing 50% (v/v) formamide, 5 x SSC, 2% (w/v) blocking reagent, 0. 1% N-lauroylsarcosine and 0.2 (w/v) SDS. The membranes were washed with 2 x SSC containing 0.1% SDS and then washed with 0.1 x SSC containing 0.1% SDS at 68°C for 30 min. Specific hybridization was detected by a DIG luminescent detection kit using lumigen-PPD as the substrate and was recorded using Kodak XAR-5 film at room temperature. To prepare membranes for rehybridization, membranes were incubated with 0.5% Tris-HCl, pH 8.0, 1% SDS and 50% formamide at 68°C for 1 h and then prehybridized as described above.
cDNA probes encoding Drosophila actin, mouse RARoc, human RARP and human RARy were prepared as previously described (Shyu et al, 1995) . The 1.7-kb cyclin A cDNA probe and the 1.4-kb cyclin B cDNA probe were kindly provided by Dr C Brechet and Dr T Hunter. The 1.25-kb GAPDH cDNA was provided by Dr R Wu. cDNAs were labelled with digoxigenin using a DNA labelling kit. The relative levels of RARa (3.5 and 2.9 kb), RARP (3.4 and 3.1 kb) and RARy (3.2 and 3.0 kb) were normalized to the level of 3-actin mRNA from the same nylon membrane. Normalizations of the levels of cyclin A and cyclin B1 were not performed because RA also induced a decreased expression of GAPDH mRNA.
Statistical analysis
The mean and standard errors of the mean (s.e.m.) of the data were calculated. Statistical analyses were performed by Student's t-test for individual and for paired samples.
RESULTS
Effect on susceptibilities of SC-Mi cells to LAK cytotoxicity by various concentrations of RA The possible change in susceptibility of SC-M I cells to LAK cytotoxicity as induced by RA was initially determined after SC-Mi cells were co-cultured with RA at various concentrations for 6 days. As shown in Figure 1 , susceptibility of SC-MI cells to LAK lysis generated from culturing PBMCs of healthy donors with IL-2 was reduced, and the reduction was RA dose dependent at concentrations ranging from 0.001-10 ,UM that were examined. A significant decrease in LAK cytotoxicity was detected at RA concentrations of 0.1 gM (P=0.0015) and 10 gIM (P=0.0002). The RA concentration of 5 ,UM was selected for further experiments.
RA at 5 gIM was added to SC-MI culture medium and SC-MI cells were harvested for LAK cytotoxicity assay after 2, 6 and 10 days of incubation. As shown in Figure 2, Figure 4 shows that a decrease in the expression of cyclin A mRNA (2.8 and 2.0 kb) and cyclin Bl mRNA (1.7 kb) was detected in SC-Ml cells after co-culture with RA (5 ,UM) for 96 h, (1997) 75(9) 
GAPDH
Northern blot analysis of RAR Because a significant resistance to LAK in SC-MI cells was detected after treatment with RA for 2 days, changes in steady-state levels of RAR mRNA in SC-MI cells treated with RA for 2 days were analysed. Following exposure to RA for 2 days, steady-state levels of two RARa mRNA transcripts (3.5 and 2.9 kb) were increased in SC-Mi cells in a RA dose-dependent manner (Figure 5, top) . The 4.8-kb band was derived from cross-hybridization with 28S ribosomal RNA and was not regulated by RA. No detectable level of RARP mRNA was observed in SC-M1 cells (Figure 5, middle) .
The expression of two RARy mRNA transcripts (3.2 and 3.0 kb) remained unchanged (Figure 5, bottom) . 
Expression of cell surface and adhesion molecules
Cytotoxicity mediated by LAK cells involves adhesive interactions between LFA-1 (CD 1 la/CD 18) and CD 2 on immune effectors and ICAM-1, -2 (CD 54 and CD 102) as well as LFA-3 (CD 58) on tumour cell targets (Robertson et al, 1990; Foreman et al, 1993) . Although LAK lysis is MHC unrestricted, the expression of MHC molecules may play a regulatory role (De Fries and Golub, 1988) . These surface and adhesion molecules and their ligands are Probes were removed and membranes were rehybridized with 0-actin probe as shown on the lower section of each panel not only important in effector to target cell adhesion, but also play a significant role in effector activation (Galandrini et al, 1992) . Therefore, whether expression of ICAM-1 and -2, LFA-3 and HLA class I and II molecules were different on SC-Mi cells from those on RA-treated SC-Mi cells was examined by flow cytometry. As shown in Table 3 , SC-MI cells expressed HLA class I, ICAM-1 and LFA-3, but not HLA class II or ICAM-2 molecules. These results indicated that the expression of these adhesion molecules was similar in SC-Mi tumour cells with and without treatment with RA.
DISCUSSION
Retinoids are becoming increasingly useful therapeutic agents for some neoplasms, such as premalignant and malignant diseases affecting the skin, head and neck, lung, bladder, uterine cervix and bone marrow (Smith et al, 1992) . Retinoids are known to exert a variety of direct effects on tumour cells, including the induction of differentiation and apoptosis (Martin et al, 1990) and the inhibition of cell proliferation (Lotan et al, 1990) . Morphological changes, alterations in expression of cell surface molecules, notably adhesion molecules, and a number of metabolic and enzymatic changes have been reported (Lotan et al, 1990; Triozzi et al, 1992; Bouillon and Audette, 1994) . Thus, the effects of retinoids on tumour cells are numerous and any of these retinoid-induced changes, alone or in combination, may contribute to the reduced sensitivity to LAKmediated cytolysis that we have described.
In the present study, we have reported that susceptibility of gastric cancer, promyelocytic leukaemia and hepatic cancer cell lines to LAK lysis was greatly reduced by RA. Similar phenomena of RA-inducible resistance to LAK cytotoxicity have also been reported. The exposure of HL-60 cells to RA, interferon-a, interferon-5 or interferon-y has produced an increased protection from LAK cytolysis (Triozzi et al, 1992) . Interferon-y has also been reported to induce protection of a variety of cancer cell lines, e.g. renal cell cancer, melanoma, sarcoma and lymphoma, from LAK cytolysis (De Fries and Golub, 1988) . Additionally reported is that phorbol 12-myristate 13-acetate, a differentiation enhancer, induced melanoma cells to generate resistance to LAK cells, while undergoing growth inhibition and neuron-like differentiation (Correale et al, 1992) .
Although interferon has been implicated as playing a role, the exact mechanisms underlying RA-enhanced resistance of cancer cells to LAK cell activity remain unknown. Any alteration of cancer cells, which may interfere with any of the stages of cell-mediated British Journal of Cancer (1997) 75(9), [1284] [1285] [1286] [1287] [1288] [1289] [1290] . Cancer Research Campaign 1997 cytotoxicity, i.e. recognition, triggering, programming and lysis, could be responsible for the decreased susceptibility of LAKmediated cytotoxicity (Apasov et al, 1993; Henkart, 1994) . These may include a reduction or masking of relevant recognition structures, a reduced ability to trigger the release of cytotoxic mediators, a decrease in transduction of cytotoxic signals and/or an increase in cellular repairing.
The recognition structures or factors on the target cancer cell surface that mediate LAK cytolysis remain largely unknown. Cellular adhesion molecules such as ICAM-1, ICAM-2, LFA-3 and MHC class I and II antigens have been proposed by some investigators as playing an auxiliary but critical role in the initial contact between immune effectors and target tumour cells, but the proposition is not universally accepted (De Fries and Golub, 1988; Robertson et al, 1990; Correale et al, 1992; Galandini et al, 1992; Triozzi et al, 1992; Fady et al, 1993; Foreman et al, 1993; Henkart, 1994; Katsanis et al, 1994) . In agreement with the majority of these reports, our results indicate that the expression of ICAM-1, ICAM-2, LFA-3 and MHC class I and II molecules are not associated with the RA-induced susceptibility of SC-Mi cells to LAK lysis. Our other data obtained from direct examination of immune effector-tumour cells conjugate formation also reveal that the recognition and contact between cancer cells and effectors are not involved. We have shown the presence of RARP and RARy mRNAs and the absence of RARf mRNA in SC-MI cells (Shyu et al, 1995 Cellular proliferation follows an orderly progression through the cell cycle. Of interest to note is that incubation of SC-M I cells with RA results in an increase in GO/GI phase and a decrease in S phase, as analysed by cell cycle distribution. Morphologically, culture with RA produces 'enlarged and flattened' SC-Ml cells (Shyu et al, 1995) . Neither a reduced viability of cells nor evidence of apoptosis, such as nuclear fragmentation or chromatin condensation, has been observed in RA-treated SC-M I cells (Shyu et al, 1995) . Cyclin analysis has revealed that cyclin A and cyclin B 1, the commonly regarded regulators of the transition to mitosis (Cordon-Cardo, 1995) , are greatly reduced. Taken together, these results suggest that RA exerts a cytostatic effect on SC-Ml cells. Furthermore, LAK-mediated cytolysis requires an active participation from the target cells that are to be metabolically active (Zychlinsky et al, 1991) . Therefore, the RA-induced cytostatic effect in SC-Mi cells may derive from such a mechanism that eventually results in a reduction of sensitivity to LAK cytotoxicity as observed. Similar observations have been reported in breast cancer cells and leukaemia cells in which susceptiblity to LAK cytotoxicities increases when target cancer cells become proliferative in response to the stimulation of oestradiol and granulocyte-monocyte colony-stimulating factor respectively (Albertini et al, 1992; Teichmann et al, 1992) . One report has shown that LAK cells are able to bind target cells independently of the cell cycle phase in Chang cell lines as measured by cytometric and morphological parameters (Nano et al, 1995) . However, binding between LAK cells and their targets is not equal to lysis. Our results in this study have also demonstrated that the binding between LAK cells and targets was unchanged by RA modification of SC-M 1 cells.
In summary, the present study has indicated that culture of SC-M1 gastric cancer cells with RA has produced a decrease in their susceptibilities to LAK-mediated cytotoxicity. The prevailing notions, such as a reduced binding between immune effectors and target tumour cells, a decreased expression of ICAM and MHC class I molecules and an alteration of RARf, appear not to be involved. The underlying mechanism is caused in part by a cytostatic effect of RA on target tumour cells. The phenomenon seen applies to a range of cell lines and further study would be advisable in those tumours for which retinoic acid therapy and IL-2 are contemplated.
